نتائج البحث

Non-Steroidal Mineralocorticoid Receptor Antagonists: A Paradigm Shift in the Management of Diabetic Nephropathy.

• Authors : Huart, Justine; Jouret, François

Subjects: Diabetic nephropathy; Finerenone; Mineralocorticoid receptor antagonist

• Source: Kidney and Blood Pressure Research, 50 (1), 267 - 275 (2025)

تفاصيل العنوان

Vignette thérapeutique de l’étudiant. Patient avec un diabète de type 2 et une maladie rénale chronique progressive

• Authors : Scheen, André; Delanaye, Pierre

Subjects: angiotensin blocker; Chronic kidney disease; Finerenone

• Source: Revue Médicale de Liège, 80 (1), 63 - 68 (2025)

تفاصيل العنوان

European Association for the Study of Diabetes 51st Annual Meeting.

• Authors : Gao HX; Close Concerns, San Francisco, California, USA.; Regier EE

Subjects: Sodium-Glucose Transporter 2 Inhibitors*; Diabetes Mellitus, Type 1/Diabetes Mellitus, Type 1/Diabetes Mellitus, Type 1/*drug therapy ; Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*drug therapy

• Source: Journal of diabetes [J Diabetes] 2016 Mar; Vol. 8 (2), pp. 177-80. Date of Electronic Publication: 2016 Jan 28.Publisher: Blackwell Publishing Asia Country of Publication: Australia NLM ID: 101504326 Publication Model: Print-Electronic Cited Medium: Internet

تفاصيل العنوان

Diabetes field cautiously upbeat despite possible setback for leading SGLT2 inhibitor.

• Authors : Jones D

Subjects: Sodium-Glucose Transporter 2 Inhibitors*; Diabetes Mellitus/Diabetes Mellitus/Diabetes Mellitus/*drug therapy ; Hypoglycemic Agents/Hypoglycemic Agents/Hypoglycemic Agents/*adverse effects

• Source: Nature reviews. Drug discovery [Nat Rev Drug Discov] 2011 Aug 31; Vol. 10 (9), pp. 645-6. Date of Electronic Publication: 2011 Aug 31.Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101124171 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

Trial watch: SGLT2 inhibitor shows promise in type 2 diabetes.

Subjects: Sodium-Glucose Transporter 2 Inhibitors*; Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*drug therapy ; Drugs, Investigational/Drugs, Investigational/Drugs, Investigational/*therapeutic use

• Source: Nature reviews. Drug discovery [Nat Rev Drug Discov] 2010 Mar; Vol. 9 (3), pp. 182.Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101124171 Publication Model: Print Cited Medium: Internet ISSN: 1474-1784

تفاصيل العنوان

Inhibiteurs des SGLT2 (gliflozines) : aux confins de la diabétologie, la cardiologie, la néphrologie et… la médecine générale.

• Authors : Scheen, André; Lancellotti, Patrizio; Delanaye, Pierre

Subjects: Chronic kidney disease; Gliflozin; Heart failure

• Source: Revue Médicale de Liège, 78 (9), 476 - 483 (2023-09)

تفاصيل العنوان

Gliflozines et finérénone : quelles perspectives pour leur association?

• Authors : Philips, Jean-Christophe; Radermecker, Régis

Subjects: finerenone; Sodium-Glucose Transporter 2 Inhibitors; Naphthyridines

• Source: Revue Médicale Suisse, 19 (838), 1503 - 1506 (2023-08-23)

تفاصيل العنوان

La fabulosa historia de las gliflozinas

• Authors : Valdes-Socin, Hernan Gonzalo; Vanoni Patiño, Miguel

Subjects: DeCS: Diabetes Mellitus, Historia, Inhibidores del Cotransportador de Sodio-Glucosa 2, Insuficiencia Cardíaca, Insuficiencia Renal Crónica MeSH: Diabetes mellitus; History; Sodium-Glucose Transporter 2 Inhibitors

• Source: Revista de la Sociedad Ecuatoriana de Nefrología (REV SEN) (2023-07)

تفاصيل العنوان

À propos de la sécurité d’emploi des inhibiteurs des SGLT2 (gliflozines).

• Authors : Scheen, André

Subjects: Hypoglycemic Agents; Sodium-Glucose Transporter 2 Inhibitors; Acute Kidney Injury/chemically induced/epidemiology

• Source: Revue Médicale de Liège, 77 (4), 218-223 (2022-04)

تفاصيل العنوان

Inhibiteurs des SGLT2 et bloqueurs du système rénine-angiotensine. Similitudes, différences et complémentarité

• Authors : Scheen, André; Delanaye, Pierre

Subjects: Angiotensin; Gliflozin; Glomerular filtration rate

• Source: Revue Médicale de Liège, 77 (1), 18 - 24 (2022)

تفاصيل العنوان